The monthly occurrence of restricting symptoms was fairly constant from 12 months before death (20.4 percent) until five months before death (27.4 percent) when it increased rapidly and reached 57.2 percent in the month before death, according to the study results.
"Our results highlight the importance of assessing and managing symptoms in older patients, particularly those with multimorbidity," the study concludes.